市場調査レポート

商品コード

1529575

薬理遺伝学検査市場：技術別、用途別、エンドユーザー別、地域別

Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction, Sequencing, Microarray Analysis, and Other Technologies), By Application, By End User, By Geography

出版日: 2024年06月27日
発行: Coherent Market Insights
ページ情報: 英文 167 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 646,065円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,004,990円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,435,700円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の薬理遺伝学検査市場は、2024年には131億1,000万米ドルと推定され、2024～2031年のCAGRは9.1％を示し、2031年には241億米ドルに達すると予測されています。

レポート範囲		レポート詳細
基準年	2023年	2024年の市場規模	131億1,000万米ドル
実績データ	2019～2023年	予測期間	2024～2031年
予測期間2024～2031年のCAGR	9.10%	2031年の金額予測	241億米ドル

図.薬理遺伝学検査市場シェア（%）、2024年、地域別

薬理遺伝学検査は、個人の遺伝的変異を調べ、薬剤の代謝と反応能力をチェックする技術です。この検査は、個人の遺伝的体質に基づいて医薬品の安全性と有効性を判断するのに役立ちます。この検査は、個人の遺伝子プロファイルに基づいて治療法、投与量、投与期間をカスタマイズする精密医療や個別化医療を実践する上で極めて重要な役割を果たしています。ゲノム技術の進歩と全ゲノム配列決定のコスト低下に伴い、薬理遺伝学検査市場は世界的に急成長しています。

市場力学：

世界の薬理遺伝学検査市場は、長期投薬が必要な慢性疾患の罹患率の上昇、個別化医療に対する需要の高まり、ゲノム技術のコスト低下、消費者直接遺伝子検査キットの採用増加によって牽引されています。しかし、薬理遺伝学検査を支持する臨床エビデンスの欠如、普及に対する医師の消極的姿勢、償還の問題が市場成長の課題となっています。ビジネス機会としては、新たなバイオマーカーを発見するための薬理遺伝学の研究活動の拡大、コンパニオン診断薬を開発するための製薬企業と診断薬企業の提携、アジアや中南米の新興諸国への進出などが挙げられます。

本調査の主要特徴

本レポートでは、世界の薬理遺伝学検査市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の薬理遺伝学検査市場の主要企業をプロファイルしています。
このレポートから洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界の薬理遺伝学検査の市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の薬理遺伝学検査市場分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

企業プロファイル
- Abbott Laboratories
- Admera Health
- Agena Bioscience
- BiogeniQ
- Bio-Rad Laboratories, Inc.
- Cepheid
- Gene by Gene, Ltd.
- Genomic Health
- Illumina, Inc.
- Laboratory Corporation of America Holdings（LabCorp）
- Myriad Genetics, Inc.
- OneOme, LLC
- OPKO Health, Inc.
- Quest Diagnostics Incorporated
- Roche Molecular Diagnostics
- Sonic Healthcare
- Thermo Fisher Scientific Inc.
- 23andMe, Inc.

第10章アナリストの推奨事項

隆盛と衰退
一貫型機会マップ

第11章参考文献と調査手法

参考文献
調査手法

Product Code: CMI7089

The global pharmacogenetic testing market is estimated to be valued at USD 13.11 Bn in 2024 and is expected to reach USD 24.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 13.11 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.10%	2031 Value Projection:	US$ 24.10 Bn

Figure. Pharmacogenetic Testing Market Share (%), By Region 2024

Pharmacogenetic testing is a technique that examines genetic variations of individuals to check their ability to metabolize and respond to drugs. It helps determine the safety and efficacy of medications for an individual based on their genetic makeup. This testing plays a pivotal role in practicing precision or personalized medicine wherein the treatment, its dosage, and duration are customized based on an individual's genetic profile. With the advancement of genomic technologies and declining costs of whole genome sequencing, the market for pharmacogenetic testing is growing rapidly worldwide.

Market Dynamics:

The global pharmacogenetic testing market is driven by rising incidence of chronic diseases requiring long term medication, growing demand for personalized healthcare, declining costs of genomic technologies, and increasing adoption of direct-to-consumer genetic testing kits. However, lack of clinical evidence supporting pharmacogenetic testing, reluctance among physicians for widespread adoption, and reimbursement issues pose challenges to the market growth. Opportunities include growing research activities in pharmacogenomics to discover new biomarkers, partnerships between pharmaceutical companies and diagnostic firms to develop companion diagnostics, and expansion into emerging Asian and Latin American countries.

Key Features of the Study:

This report provides in-depth analysis of the global pharmacogenetic testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmacogenetic testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Illumina, Inc, Abbott Laboratories, F. Hoffmann-La Roche Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmacogenetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenetic testing market

Detailed Segmentation-

By Technology
- Polymerase Chain Reaction (PCR)
- Sequencing
- Microarray Analysis
- Other Technologies
By Application
- Cardiology
- Gastroenterology
- Endocrinology
- Immunology & Hypersensitivity
- Gynecology
- Oncology
- Neurology
- Others
By End User
- Hospitals & Clinics
- Academic & Research Institutes
- Biopharmaceutical Companies
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Admera Health
- Agena Bioscience
- BiogeniQ
- Bio-Rad Laboratories, Inc.
- Cepheid
- Gene by Gene, Ltd.
- Genomic Health
- Illumina, Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Myriad Genetics, Inc.
- OneOme, LLC
- OPKO Health, Inc.
- Quest Diagnostics Incorporated
- Roche Molecular Diagnostics
- Sonic Healthcare
- Thermo Fisher Scientific Inc.
- 23andMe, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Pharmacogenetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Pharmacogenetic Testing Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Polymerase Chain Reaction (PCR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microarray Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Technologies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmacogenetic Testing Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gastroenterology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Endocrinology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunology & Hypersensitivity
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gynecology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmacogenetic Testing Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmacogenetic Testing Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Admera Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agena Bioscience
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BiogeniQ
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cepheid
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Gene by Gene, Ltd.
- Genomic Health
- Illumina, Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Myriad Genetics, Inc.
- OneOme, LLC
- OPKO Health, Inc.
- Quest Diagnostics Incorporated
- Roche Molecular Diagnostics
- Sonic Healthcare
- Thermo Fisher Scientific Inc.
- 23andMe, Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Reference and Research Methodology

References
Research Methodology
About us and Sales Contact

薬理遺伝学検査市場：技術別、用途別、エンドユーザー別、地域別

Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction, Sequencing, Microarray Analysis, and Other Technologies), By Application, By End User, By Geography

市場力学：

本調査の主要特徴

目次

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界の薬理遺伝学検査市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界の薬理遺伝学検査市場、技術別、2019～2031年（10億米ドル）

第6章世界の薬理遺伝学検査市場、用途別、2019～2031年（10億米ドル）

第7章世界の薬理遺伝学検査市場、エンドユーザー別、2019～2031年（10億米ドル）

第8章世界の薬理遺伝学検査市場、地域別、2019～2031年（10億米ドル）

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pharmacogenetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pharmacogenetic Testing Market, By Technology, 2019 - 2031, (USD Bn)

6. Global Pharmacogenetic Testing Market, By Application, 2019 - 2031, (USD Bn)

7. Global Pharmacogenetic Testing Market, By End User, 2019 - 2031, (USD Bn)

8. Global Pharmacogenetic Testing Market, By Region, 2019 - 2031, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Reference and Research Methodology

薬理遺伝学検査市場：技術別、用途別、エンドユーザー別、地域別

Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction, Sequencing, Microarray Analysis, and Other Technologies), By Application, By End User, By Geography

市場力学：

本調査の主要特徴

目次

第1章 調査の目的と前提条件

第2章 市場展望

第3章 市場力学、規制、動向分析

第4章 世界の薬理遺伝学検査市場-コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の薬理遺伝学検査市場、技術別、2019～2031年（10億米ドル）

第6章 世界の薬理遺伝学検査市場、用途別、2019～2031年（10億米ドル）

第7章 世界の薬理遺伝学検査市場、エンドユーザー別、2019～2031年（10億米ドル）

第8章 世界の薬理遺伝学検査市場、地域別、2019～2031年（10億米ドル）

第9章 競合情勢

第10章 アナリストの推奨事項

第11章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pharmacogenetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pharmacogenetic Testing Market, By Technology, 2019 - 2031, (USD Bn)

6. Global Pharmacogenetic Testing Market, By Application, 2019 - 2031, (USD Bn)

7. Global Pharmacogenetic Testing Market, By End User, 2019 - 2031, (USD Bn)

8. Global Pharmacogenetic Testing Market, By Region, 2019 - 2031, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Reference and Research Methodology

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界の薬理遺伝学検査市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界の薬理遺伝学検査市場、技術別、2019～2031年（10億米ドル）

第6章世界の薬理遺伝学検査市場、用途別、2019～2031年（10億米ドル）

第7章世界の薬理遺伝学検査市場、エンドユーザー別、2019～2031年（10億米ドル）

第8章世界の薬理遺伝学検査市場、地域別、2019～2031年（10億米ドル）

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法